← back to search

Maximilian Deng

Heidelberg University · DE
🔎 Find collaborators in Genetics · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Meningioma and schwannoma management, and Radiation Therapy and Dosimetry.
h-index
12
citations
678
works
69
NIH funding
primary concept
email

Recent publications

IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread
Acta Neuropathologica 2025cited by 7position: middledoi
Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profiles
Neuro-Oncology 2025cited by 2position: firstdoi
Combined Spatial and Dosimetric Recurrence Pattern Analysis in Head and Neck Squamous Cell Carcinoma Following Postoperative (Chemo)radiotherapy
Radiation Oncology 2025cited by 1position: middledoi
Outcomes and recurrence pattern analysis of intensity modulated chemoradiotherapy in nasopharyngeal cancer: a retrospective study from Heidelberg University Hospital
Radiation Oncology 2025cited by 1position: middledoi
Randomized Controlled Trial of Semi-Individualized 3d-Printed Tissue Retraction Devices vs. Conventional Splints in Head and Neck Cancer Treated with Intensity-Modulated and Particle Radiotherapy (Guard)
SSRN Electronic Journal 2025cited by 1position: middledoi
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Nature Medicine 2024cited by 63position: middledoi
Radiation-Induced Cerebral Contrast Enhancements Strongly Share Ischemic Stroke Risk Factors
International Journal of Radiation Oncology*Biology*Physics 2024cited by 6position: middledoi
Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases – Clinical outcome and prognostic factors
Clinical and Translational Radiation Oncology 2024cited by 6position: middledoi
Efficacy and toxicity of photon, proton, and carbon ion radiotherapy in the treatment of intracranial solitary fibrous tumor/hemangiopericytoma
Radiation Oncology 2024cited by 5position: middledoi
Helium Ion Therapy for Advanced Juvenile Nasopharyngeal Angiofibroma
Cancers 2024cited by 4position: middledoi
Efficacy of palliative hemostatic radiotherapy for tumor bleeding and pain relief in locally advanced pelvic gynecological malignancies
Strahlentherapie und Onkologie 2024cited by 4position: middledoi
Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07)
BMC Cancer 2024cited by 2position: firstdoi
Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningioma
Neuro-Oncology Advances 2024cited by 1position: firstdoi
Fractionated stereotactic radiotherapy of brainstem metastases – Clinical outcome and prognostic factors
Clinical and Translational Radiation Oncology 2024cited by 1position: middledoi
Mapping pediatric brain tumors to their origins in the developing cerebellum
Neuro-Oncology 2023cited by 47position: middledoi
To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes
Lung Cancer 2023cited by 18position: middledoi
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial
Neuro-Oncology 2023cited by 18position: firstdoi
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3
Journal of Neuro-Oncology 2023cited by 17position: middledoi
Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy
Radiation Oncology 2023cited by 12position: middledoi
Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids
Clinical and Translational Radiation Oncology 2023cited by 11position: middledoi
Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification
Neuro-Oncology Advances 2023cited by 10position: firstdoi
Proton Therapy for Advanced Juvenile Nasopharyngeal Angiofibroma
Cancers 2023cited by 10position: middledoi
RADT-40. FINAL RESULTS OF THE PROSPECTIVE PHASE 2 MARCIE TRIAL: EFFICACY AND TOXICITY OF POSTOPERATIVE BIMODAL RADIOTHERAPY WITH C12-BOOST IN PATIENTS WITH ATYPICAL MENINGIOMAS FOLLOWING SUBTOTAL RESECTION
Neuro-Oncology 2023cited by 1position: firstdoi
Radiotherapy with Helium Ions Has the Potential to Improve Both Endocrine and Neurocognitive Outcome in Pediatric Patients with Ependymoma
Cancers 2022cited by 13position: middledoi
MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear Clusters
American Journal of Neuroradiology 2022cited by 12position: middledoi
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma
Journal of Clinical Oncology 2021cited by 84position: middledoi
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B
Nature Communications 2021cited by 52position: firstdoi
Mapping pediatric brain tumors to their origins in the developing cerebellum
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 8position: middledoi
MBCL-08. INTEGRATIVE MOLECULAR ANALYSIS OF PATIENT-MATCHED DIAGNOSTIC AND RELAPSED MEDULLOBLASTOMAS
Neuro-Oncology 2020cited by 0position: middledoi
Diffuse glioneuronal tumour with oligodendroglioma‐like features and nuclear clusters (DGONC) – a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14
Neuropathology and Applied Neurobiology 2019cited by 80position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Jürgen Debus · NYU Langone Health18 papers (2022–2025)Laila König · Heidelberg University15 papers (2023–2025)Juliane Hörner‐Rieber · German Cancer Research Center14 papers (2023–2025)Tanja Eichkorn · Heidelberg University14 papers (2023–2025)Klaus Herfarth · Universitätsklinik für Strahlentherapie13 papers (2022–2025)Sebastian Regnery · Brigham and Women's Hospital11 papers (2023–2025)Eva Meixner · DKFZ-ZMBH Alliance11 papers (2023–2024)Thomas Held · Heidelberg University11 papers (2023–2025)Jonathan W. Lischalk · New York University11 papers (2023–2025)Katharina Seidensaal · Heidelberg University8 papers (2022–2025)Andreas von Deimling · Stiftung Schleswig-Holsteinische Landesmuseen8 papers (2018–2025)Felix Sahm · Heidelberg (Poland)8 papers (2018–2025)Kristin Lang · Heidelberg University7 papers (2023–2025)Stefan M. Pfister · Université du Québec7 papers (2018–2025)Lukas Bauer · German Cancer Research Center7 papers (2023–2025)Wolfgang Wick · Heidelberger Institut für Radioonkologie6 papers (2023–2025)Antje Wick · Heidelberg University5 papers (2023–2025)Elisabetta Sandrini · University Hospital Heidelberg5 papers (2023–2024)Christine Jungk · University Hospital Heidelberg5 papers (2023–2025)Anna Krämer · Johannes Gutenberg University Mainz5 papers (2023–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Genetics · Pulmonary and Respiratory Medicine →